Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
iShares US Medical Devices ETF
IHI
$3.37B
| $51.6M | 0.04% |
1,022,249
+95,812
| +10% | +$5.22M |
|
202
iShares MBS ETF
MBB
$38.8B
| $51.5M | 0.04% |
528,526
+18,989
| +4% | +$1.86M |
|
203
Occidental Petroleum
OXY
$55.2B
| $49.7M | 0.04% |
844,351
+1,100
| +0.1% | +$67.6K |
|
204
Medpace
MEDP
$16B
| $49M | 0.03% |
327,505
+22,592
| +7% | +$3.27M |
|
205
Polaris
PII
$4.02B
| $48.7M | 0.03% |
490,623
-10,200
| -2% | -$1.06M |
|
206
Fair Isaac
FICO
$22.6B
| $48.4M | 0.03% |
120,734
-2,801
| -2% | -$1.1M |
|
207
Invesco NASDAQ Internet ETF
PNQI
$533M
| $48.4M | 0.03% |
2,024,760
+196,585
| +11% | +$5.38M |
|
208
First American
FAF
$7.7B
| $48.3M | 0.03% |
912,280
+76,558
| +9% | +$4.46M |
|
209
iShares MSCI Japan ETF
EWJ
$22B
| $47.2M | 0.03% |
893,183
+36,511
| +4% | +$2.06M |
|
210
Walt Disney
DIS
$170B
| $46.4M | 0.03% |
491,280
-65,292
| -12% | -$7.25M |
|
211
iShares Core US Aggregate Bond ETF
AGG
$137B
| $46M | 0.03% |
452,588
+31,061
| +7% | +$3.19M |
|
212
Helmerich & Payne
HP
$3.41B
| $45.1M | 0.03% |
1,047,976
-107,490
| -9% | -$4.99M |
|
213
Halozyme
HALO
$9.76B
| $44.7M | 0.03% |
1,015,289
+73,775
| +8% | +$3.19M |
|
214
ON Semiconductor
ON
$31.3B
| $44.7M | 0.03% |
887,781
+36,271
| +4% | +$2.02M |
|
215
Bank of America
BAC
$438B
| $43.6M | 0.03% |
1,399,849
-23,611
| -2% | -$850K |
|
216
Cummins
CMI
$89.5B
| $43.5M | 0.03% |
224,904
-8,901
| -4% | -$1.78M |
|
|
NEX
217
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $43.4M | 0.03% |
4,561,019
-1,095,218
| -19% | -$11.5M |
|
218
Diageo
DEO
$49.2B
| $43.3M | 0.03% |
248,487
-266
| -0.1% | -$50.6K |
|
|
PACW
219
DELISTED
PacWest Bancorp
PACW
| $43M | 0.03% |
1,613,091
+471,258
| +41% | +$15.2M |
|
220
Sally Beauty Holdings
SBH
$1.54B
| $42.7M | 0.03% |
3,582,226
-32,672
| -0.9% | -$475K |
|
221
Boston Beer
SAM
$1.94B
| $42.4M | 0.03% |
139,840
+7,194
| +5% | +$2.5M |
|
222
Webster Financial
WBS
$12.6B
| $42.1M | 0.03% |
999,696
+139,304
| +16% | +$6.71M |
|
223
Knowles
KN
$3.2B
| $40.9M | 0.03% |
2,362,549
-42,416
| -2% | -$797K |
|
224
Prestige Consumer Healthcare
PBH
$2.46B
| $39.8M | 0.03% |
676,175
-15,743
| -2% | -$868K |
|
225
ENI
E
$79B
| $39.2M | 0.03% |
1,644,574
-4,338
| -0.3% | -$124K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.